GTC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Genes to Cells (2006) 11, 363-371. doi:10.1111/j.1365-2443.2006.00944.x
© 2006 Blackwell Publishing or its licensors

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by So, S.
Right arrow Articles by Koyama, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by So, S.
Right arrow Articles by Koyama, H.

Enhanced gene targeting efficiency by siRNA that silences the expression of the Bloom syndrome gene in human cells

Sairei So1,{dagger}, Yuji Nomura1,{dagger}, Noritaka Adachi1, Yuki Kobayashi1, Tamaki Hori2, Yasuyuki Kurihara2 and Hideki Koyama1,*

1 Kihara Institute for Biological Research, Graduate School of Integrated Science, Yokohama City University, Maioka-cho 641-12, Totsuka-ku, Yokohama 244-0813, Japan
2 Department of Environment and Natural Sciences, Graduate School of Environment and Information Sciences, Yokohama National University, Tokiwadai 79-5, Hodogaya-ku, Yokohama 240-8501, Japan

Gene targeting via homologous recombination is a powerful tool for studying gene function, but the targeting efficiency in human cell lines is too low for generating knockout mutants. Several cell lines null for the gene responsible for Bloom syndrome, BLM, have shown elevated targeting efficiencies. Therefore, we reasoned that gene targeting would be enhanced by transient suppression of BLM expression by RNA interference. To test this, we constructed a gene correction assay system to measure gene targeting frequencies using a disrupted hypoxanthine phosphoribosyltransferase (HPRT) locus in the human HT1080 cell line, and examined the effect of small interfering RNA (siRNA) for BLM on gene targeting. When HPRT-null cells pretreated with BLM siRNA were co-transfected with the siRNA and a gene correction vector, the gene targeting frequency was elevated three-fold, while the random integration frequency was marginally affected. Remarkably, in BLM heterozygous (+/–) cells derived from HPRT-null cells, the BLM siRNA treatment gave more than five-fold higher targeting frequencies, even with one-tenth the amount of BLM siRNA used for BLM+/+ cells. Furthermore, in the human pre-B cell line Nalm-6, the siRNA treatment enhanced gene targeting 6.3-fold and > 5.8-fold at the HPRT and adenine phosphoribosyltransferase (APRT) loci, respectively. These results indicate that transient suppression of BLM expression by siRNA stimulates gene targeting in human cells, facilitating a further improvement of gene targeting protocols for human cell lines.


Communicated by: Hiroshi Handa

{dagger}These authors contributed equally to this work.

* Correspondence: E-mail: koyama{at}yokohama-cu.ac.jp




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Kikuchi, H. I. Abdel-Aziz, Y. Taniguchi, M. Yamazoe, S. Takeda, and K. Hirota
Bloom DNA Helicase Facilitates Homologous Recombination between Diverged Homologous Sequences
J. Biol. Chem., September 25, 2009; 284(39): 26360 - 26367.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Iiizumi, A. Kurosawa, S. So, Y. Ishii, Y. Chikaraishi, A. Ishii, H. Koyama, and N. Adachi
Impact of non-homologous end-joining deficiency on random and targeted DNA integration: implications for gene targeting
Nucleic Acids Res., November 1, 2008; 36(19): 6333 - 6342.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Toyoda, S. Kagaya, I. G. Cowell, A. Kurosawa, K. Kamoshita, K. Nishikawa, S. Iiizumi, H. Koyama, C. A. Austin, and N. Adachi
NK314, a Topoisomerase II Inhibitor That Specifically Targets the {alpha} Isoform
J. Biol. Chem., August 29, 2008; 283(35): 23711 - 23720.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
Y. Nomura, N. Adachi, and H. Koyama
Human Mus81 and FANCB independently contribute to repair of DNA damage during replication
Genes Cells, October 1, 2007; 12(10): 1111 - 1122.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS
Copyright © 2006 by Wiley-Blackwell Publishing.